Health

Four out of five pregnant women in Ireland are iron deficient by their third trimester, a University College Cork (UCC) study reveals. Researchers at the Irish Centre for Maternal and Child Health (INFANT) and School of Food and Nutritional Sciences […]

Video content above is prompted by the following: Evaluate the efficacy and safety profiles of current and emerging HER2-directed therapies in NSCLC, and their potential impact on treatment paradigms. (Bazhenova) Describe the difference between HER2 mutation and HER2 expression. (Kim)

Former President Jimmy Carter is just days away from turning 99, having defied the odds of dying from a brain cancer with an 80 percent mortality rate.  The almost-centenarian was diagnosed with stage 4 melanoma in 2015 that had spread to

Banned at conception or after 6 weeks Banned after 12-13 weeks Banned after 15-18 weeks The US supreme court’s decision to overturn Roe v Wade may have abolished the national right to abortion, but the state-by-state battle for abortion rights

Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers unexpectedly finds that estrogens play a role in fueling the growth of breast cancers without the

Kidney failure, also called end-stage renal disease (ESRD), is a condition where your kidneys are functioning at 15% of their normal levels. Kidneys help filter out waste products and excessive fluids from your body. Kidney failure may occur due to

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals from the FDA for use in non–small cell lung cancer (NSCLC). Here we continue our discussion with Joshua K. Sabari,

A little girl in Arizona went 30 hours with snake venom coursing through her veins after doctors dismissed her symptoms. Allie Brasfield, 7, was on a family vacation earlier this month when she tripped in the grass and quickly brushed it

Currently there are no cures for rheumatoid arthritis (RA) which affects 40,000 people in Ireland. The disease costs an estimated €20,000 per patient, per year with an overall cost to the health system of ~€544 million. Only 1 in 4

Video content above is prompted by the following: What factors guide the choice between fam-trastuzumab deruxtecan-nxki and ado-trastuzumab emtansine? What key insights emerged from pivotal trials like the phase 2 basket DESTINY-Lung01and DESTINY-Lung02? How do real-world patient outcomes compare with